Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Rockenstein

Showing results (81-90 of 197) with videos related to

Pageof 20
Sort By:
Journal of Neuroscience Research|May 1, 2009
Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophyKiren Ubhi, Phil Hyu Lee, Anthony Adame, et al.
The European Journal of Neuroscience|January 4, 2012
Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse modelZacharias Kohl, Beate Winner, Kiren Ubhi, et al.
Stem Cell Research|July 27, 2015
Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer diseaseEdward Rockenstein, Paula Desplats, Kiren Ubhi, et al.
Traffic (Copenhagen, Denmark)|August 19, 2018
T-complex protein 1-ring complex enhances retrograde axonal transport by modulating tau phosphorylationXu-Qiao Chen, Fang Fang, Jazmin B Florio, et al.
Molecular Brain|September 28, 2012
Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H β-synucleinAkio Sekigawa, Masayo Fujita, Kazunari Sekiyama, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synucleinPaula Desplats, He-Jin Lee, Eun-Jin Bae, et al.
Journal of Alzheimer'S Disease : JAD|January 15, 2018
Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat TauAndrew Arner, Edward Rockenstein, Michael Mante, et al.
Annals of Clinical and Translational Neurology|September 9, 2016
α-synuclein conformational antibodies fused to penetratin are effective in models of Lewy body diseaseBrian Spencer, Stephanie Williams, Edward Rockenstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 27, 2003
Neprilysin gene transfer reduces human amyloid pathology in transgenic miceRobert A Marr, Edward Rockenstein, Atish Mukherjee, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 14, 2011
Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synucleinDarius Ebrahimi-Fakhari, Ippolita Cantuti-Castelvetri, Zhanyun Fan, et al.
Pageof 20

Showing results (81-90 of 197) with videos related to

Sort By:
Pageof 20
Journal of Neuroscience Research|May 1, 2009
Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophyKiren Ubhi, Phil Hyu Lee, Anthony Adame, et al.
The European Journal of Neuroscience|January 4, 2012
Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse modelZacharias Kohl, Beate Winner, Kiren Ubhi, et al.
Stem Cell Research|July 27, 2015
Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer diseaseEdward Rockenstein, Paula Desplats, Kiren Ubhi, et al.
Traffic (Copenhagen, Denmark)|August 19, 2018
T-complex protein 1-ring complex enhances retrograde axonal transport by modulating tau phosphorylationXu-Qiao Chen, Fang Fang, Jazmin B Florio, et al.
Molecular Brain|September 28, 2012
Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H β-synucleinAkio Sekigawa, Masayo Fujita, Kazunari Sekiyama, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synucleinPaula Desplats, He-Jin Lee, Eun-Jin Bae, et al.
Journal of Alzheimer'S Disease : JAD|January 15, 2018
Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat TauAndrew Arner, Edward Rockenstein, Michael Mante, et al.
Annals of Clinical and Translational Neurology|September 9, 2016
α-synuclein conformational antibodies fused to penetratin are effective in models of Lewy body diseaseBrian Spencer, Stephanie Williams, Edward Rockenstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 27, 2003
Neprilysin gene transfer reduces human amyloid pathology in transgenic miceRobert A Marr, Edward Rockenstein, Atish Mukherjee, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 14, 2011
Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synucleinDarius Ebrahimi-Fakhari, Ippolita Cantuti-Castelvetri, Zhanyun Fan, et al.
Pageof 20